Labelled expenditure is defined as that which is included in budgets, is drug-specific and is proactive, in that it is linked to the achievement of specific policy aims. Home Office labelled expenditure for the current financial year is £160.39 million. While precise figures for Home Office labelled expenditure are not yet available for the financial years 2009-10 and 2010-11, it is expected that the figure will remain broadly stable.
In addition to labelled expenditure, the Home Office meets the costs of activity which is reactive, such as enforcement of the laws surrounding drugs.
Further details of the resources invested by Government departments are set out in an appendix to the drug strategy, which can be viewed at: